Multicenter Prospective Observational Study on Prostate Salvage Using High-dose-rate Brachytherapy.
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
A prospective, observational, multicenter study analyzing salvage treatment for prostate cancer-diagnosed via next-generation imaging (Choline PET/PSMA PET), MRI, and positive biopsy-using two fractions of high-dose-rate (HDR) brachytherapy.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Wiek powyżej 18 lat
- •Potwierdzony miejscowy nawrót raka prostaty widoczny w nowoczesnym obrazowaniu i badaniu biopsji
- •Rak wrażliwy na leczenie hormonalne
- •Poprzednie leczenie brachyterapią, radioterapią lub kombinacją obu metod
✗ Disqualifies
- •Przerzuty nowotworu na inne narządy
- •Rak prostaty oporny na obniżanie poziomu testosteronu (mimo leczenia hormonalnego)
- •Niepowodzenie kilku kolejnych linii leczenia hormonalnego
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Last updated (source)
- October 9, 2026
- Sex
- No restrictions
Locations (10)
Hospital HCB Benidorm
Benidorm, Spain
Instituto Catalán de Oncología L'Hospitalet
L'Hospitalet de Llobregat, Spain
Hospital Universitario Marqués de Valdecilla
Santander, Spain
Hospital Universitario Reina Sofía
Córdoba, Spain
Instituto Oncológico de San Sebastián (Onkologikoa)
San Sebastián, Spain
Hospital Universitario Ramón y Cajal
Madrid, Spain
Hospital Universitario de Navarra
Pamplona, Spain
Hospital Meixoeiro
Vigo, Spain
Hospital Universitario y Politécnico La Fe
Valencia, Spain
Hospital Universitario de Cruces
Barakaldo, Spain
Trial contact
Patricia Willisch Santamaría, MD PhD
Pablo Raña Díez
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 10/7/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.